白屈菜红碱 | 478-03-5

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 苯并菲啶生物碱
• 中文名称: 白屈菜红碱
• 英文名称: Chelerythrine
• 英文别名: 1,2-dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridinium; hydroxide；1,2-Dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridinium; Hydroxid；Chelerythrine hydroxide；1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;hydroxide
• CAS: 478-03-5
• 化学式: C₂₁H₁₈NO₄*HO
• 分子量: 365.386
• InChiKey: YZYNINHQZLUUAW-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  3.54
• 重原子数：
  27
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  41.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  白屈菜红碱 生成 N-(2-chloroethyl)-N-[2-(7,8-dimethoxy-5-methylbenzo[c]phenanthridin-5-ium-2-yl)oxyethyl]-2-oxo-1,3,2λ5-oxazaphosphinan-2-amine;dihydroxide;hydrochloride
  参考文献：
  名称：

  摘要：

  DOI：
• 作为产物：
  描述：

  (E)-1-(1,3-benzodioxol-5-yl)-3-(7-methoxy-2-methyl-1-benzofuran-4-yl)prop-2-en-1-one 在 对甲苯磺酸 作用下， 生成 白屈菜红碱
  参考文献：
  名称：

  Cesium fluoride-mediated claisen rearrangement of aryl propargyl ether and its application to the synthesis of chelerythrine.

  摘要：

  在氟化铯存在下，芳基丙炔醚的克莱森重排选择性地提供了 2-甲基苯并呋喃，依次用四氧化锇、定期酸和 5%氢氧化钠处理后得到水杨醛，收率很高。如图 3 所示，该方法通过两种路线制备的共同中间体 (8) 合成了白屈菜红碱 (2)。

  DOI：

  10.1248/cpb.38.1775

文献信息

• [EN] POLYCATIONIC AMPHIPHILES AND POLYMERS THEREOF AS ANTIMICROBIAL AGENTS AND METHODS USING SAME<br/>[FR] COMPOSÉS AMPHIPHILES POLYCATIONIQUES ET LEURS POLYMÈRES UTILISABLES EN TANT QU'AGENTS ANTIMICROBIENS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

  公开号：WO2016172436A1

  公开（公告）日：2016-10-27

  The present invention includes novel polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes novel polymers of polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes methods useful for removing microorganisms and/or biofilm-embedded microorganisms from a surface. The present invention further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms and/or biofilm-embedded microorganisms on a surface.

  本发明包括新型的具有抗菌作用的多阳离子两性化合物。本发明还包括新型的多阳离子两性化合物聚合物，用作抗菌剂。本发明还包括用于从表面去除微生物和/或生物膜中嵌入的微生物的方法。本发明还包括用于预防或减少微生物和/或生物膜中嵌入的微生物在表面上生长或繁殖的组合物和方法。
• [EN] ANTICANCER CONJUGATE<br/>[FR] CONJUGUÉ ANTICANCÉREUX
  申请人：ADAMED SP ZOO

  公开号：WO2014141094A1

  公开（公告）日：2014-09-18

  An anticancer conjugate, which comprises a fusion protein comprising domain (a), which is the functional fragment of a sequence of soluble human TRAIL (hTRAIL) protein beginning with an amino acid at a position not lower than hTRAIL95 or a sequence having at least 70% identity with said functional fragment, domain (b) which is the sequence of an effector peptide having proapoptotic, antiangiogenic, antiproliferative or pore forming activity, and conjugation domain (d) for attachment of a chemical compound selected from the group consisting of the sequences Cys Ala Ala Ala Cys Ala Ala Cys and Cys Ala Ala Cys Ala Ala Ala Cys, and a molecule of a chemical compound Z having antiblastic activity, which is attached to said conjugation domain (d) of said fusion protein directly or via a conjugation linker L.

  一种抗癌结合物，包括融合蛋白，该融合蛋白包括以下部分：（a）功能性片段，该片段是以不低于hTRAIL95位置的氨基酸开始的可溶性人类TRAIL（hTRAIL）蛋白序列的片段，或者具有与该功能性片段至少70%同源性的序列；（b）是具有促凋亡、抗血管生成、抗增殖或形成孔活性的效应肽序列；以及（d）用于连接来自以下序列的化学化合物的结合结构域，该序列包括Cys Ala Ala Ala Cys Ala Ala Cys和Cys Ala Ala Cys Ala Ala Ala Cys，以及具有抗肿瘤活性的化学化合物Z的分子，该分子附着在所述融合蛋白的结合结构域（d）上，直接或通过结合连接物L连接。
• [EN] ANTIFUNGAL COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ANTI-FONGIQUES ET UTILISATIONS ASSOCIÉES
  申请人：DANA FARBER CANCER INST INC

  公开号：WO2017143230A1

  公开（公告）日：2017-08-24

  Provided herein are compounds (e.g., compounds of Formulae (I), (II), and (III)) which are anti-fungal agents and can be used in the treatment of diseases, including infectious diseases. The invention provides methods of treating diseases in a subject (e.g., infectious diseases such as fungal infections), and methods of killing or inhibiting the growth of fungi in or on a subject or biological sample. The compounds may be used in subjects, in clinical settings, or in agricultural settings.

  本发明提供了化合物（例如，公式(I)、(II)和(III)的化合物），这些化合物是抗真菌剂，可用于治疗包括传染性疾病在内的疾病。本发明还提供了在主体（例如，真菌感染等传染性疾病）中治疗疾病的方法，以及杀死或抑制主体或生物样本内或上的真菌生长的方法。这些化合物可用于主体、临床环境或农业环境。
• Mst1 modulation of apoptosis in cardiac tissue and modultors of Mst1 for treatment and prevention of cardiac disease
  申请人：——

  公开号：US20040213794A1

  公开（公告）日：2004-10-28

  The present invention relates to methods and agents for treatment, amelioration and prevention of cardiac disease, including cardiac myopathy, chronic heart failure and for management and reduction of cardiac myocyte death which may occur in response to ischemia/reperfusion or following myocardial infarction or other injury to the heart. The invention relates to methods for screening cardiotherapeutic compounds, including compounds which modulate cardiac myocyte apoptosis, particularly targeting Mst1 and the Mst1 pathway. The present invention further encompasses compounds identified by such screening methods and compositions comprising these compounds. The invention also provides methods for treatment, amelioration and prevention of cardiac disease comprising administering compounds or agents which modulate, particularly inhibit, Mst1 or the Mst1 kinase pathway, including administering a nucleic acid encoding an altered form of Mst1, particularly a dominant negative Mst1, which acts as an antagonist of Mst1.

  本发明涉及用于治疗、改善和预防心脏疾病的方法和药剂，包括心肌病、慢性心力衰竭的治疗，以及用于管理和减少心肌细胞死亡的方法，这种死亡可能是由于缺血/再灌注或心肌梗死或其他心脏损伤引起的。该发明涉及筛选心脏治疗化合物的方法，包括调节心肌细胞凋亡的化合物，特别是针对Mst1和Mst1途径的化合物。本发明进一步涵盖通过这种筛选方法确定的化合物和含有这些化合物的组合物。该发明还提供了治疗、改善和预防心脏疾病的方法，包括给予调节、特别是抑制Mst1或Mst1激酶途径的化合物或药剂，包括给予编码改变形式的Mst1的核酸，特别是充当Mst1拮抗剂的优势阴性Mst1的核酸。
• NOVEL COMPOUNDS AS CHLORIDE CHANNEL BLOCKING AGENT
  申请人：Korea Institute of Science and Technology

  公开号：US20150148550A1

  公开（公告）日：2015-05-28

  Disclosed is a novel compound to function as a calcium-dependent chloride channel blocking agent.

  披露了一种新型化合物，用作钙依赖性氯离子通道阻滞剂。